Farxiga: Clinical Trials

2 trials of Farxiga, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Farxiga: new trials by email Literature Review of Farxiga trials Research Report on Farxiga

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus
Dapagliflozin 10mg, Saxagliptin 5mg, Placebo Oral Tablet - Diabetes Mellitus, Type 2, Cardiovascular Diseases
Phase 4TerminatedSabyasachi Sen152018-10-222023-06-05
Effect of Dapagliflozin on Inflammation and Endothelial Function
Dapagliflozin, Placebo - Type 2 Diabetes Mellitus
Phase 4TerminatedBaylor College of Medicine172015-11-012020-04-08

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Cardiovascular Diseases (1)

Sponsors

Baylor College of Medicine (1)  ·  Sabyasachi Sen (1)

Countries

United States (2)

Top investigators

Mandeep Bajaj, MD (1)  ·  Sabyasachi Sen, MD, PhD (1)

Results publications

PMID 39865301